XML 110 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues $ 117,613 $ 117,438 $ 124,753
Costs of revenues (1) [1] 58,066 59,991 67,058
Gross profit 59,547 57,447 57,695
Operating expenses:      
Research and development [2] 35,552 36,109 36,655
Sales and marketing [3] 17,665 15,323 14,315
General and administrative [4] 10,317 9,955 9,789
Amortization of intangible assets 417 1,700 1,700
Total operating expenses 63,951 63,087 62,459
Operating loss (4,404) (5,640) (4,764)
Financial income, net (Note 12) 1,654 1,815 1,669
Loss before income tax benefit (2,750) (3,825) (3,095)
Income tax benefit (Note 15) 1,560 1,868 92
Net loss $ (1,190) $ (1,957) $ (3,003)
Net loss per share:      
Basic and diluted (in dollars per share) $ (0.05) $ (0.09) $ (0.14)
Weighted average number of shares used in per share computations of:      
Basic and diluted net loss per share (in shares) 22,827 22,512 22,229
[1] Includes equity-based compensation expense in the amount of $448, $428 and $352 for the years ended December 31, 2019, 2018 and 2017, respectively.
[2] Includes equity-based compensation expense in the amount of $2,842, $2,873 and $2,349 for the years ended December 31, 2019, 2018 and 2017, respectively.
[3] Includes equity-based compensation expense in the amount of $1,758, $1,248 and $1,115 for the years ended December 31, 2019, 2018 and 2017, respectively.
[4] Includes equity-based compensation expense in the amount of $2,583, $2,255 and $2,045 for the years ended December 31, 2019, 2018 and 2017, respectively.